Gcp Compliance And Managing Clinical Trials During Covid-19
An overview of complying with GCP and discussion of how Covid-19 has impacted the management of Clinical Trials.
What you’ll learn
- This course will begin with a brief introduction to compliance with Good Clinical Practice (GCP). The second part will focus on managing Clinical Trials with restrictions and uncertainties brought about by Covid-19.
- A basic knowledge of GCP and managing clinical trials.
This course will with a brief overview of complying with GCP, then moving onto discussing how Covid-19 has impacted the way Clinical Trials are being managed. This included discussing challenges with patient safety and Investigational Medicinal Products (IMPs). We also looked at how the regulations from the European Medicines Agency, MHRA and the US Food and Drug Administration have been impacted by these changes.
Author(s): Linda Hopkinson